106 related articles for article (PubMed ID: 9864813)
1. [Experience in heptral treatment of diffuse liver diseases].
Gorbakov VV; Galik VP; Kirillov SM
Ter Arkh; 1998; 70(10):82-6. PubMed ID: 9864813
[TBL] [Abstract][Full Text] [Related]
2. [Clinical trial of heptral in patients with chronic diffuse liver disease with intrahepatic cholestasis syndrome].
Podymova SD; Nadinskaia MIu
Klin Med (Mosk); 1998; 76(10):45-8. PubMed ID: 9865018
[TBL] [Abstract][Full Text] [Related]
3. [Heptral potentialities in the treatment of hepatic damage in children with malignant blood disease].
Reĭzis AR; Nurmukhametova EA
Ter Arkh; 1998; 70(10):48-51. PubMed ID: 9864805
[TBL] [Abstract][Full Text] [Related]
4. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
[TBL] [Abstract][Full Text] [Related]
5. [Chronic viral infection in patients with alcoholic liver involvement].
Nikitin IG; Storozhakov GI; Volynkina VM; Uskov IuI; Kisliakov VA; Shilo VIu
Ter Arkh; 1998; 70(2):40-4. PubMed ID: 9551570
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
[TBL] [Abstract][Full Text] [Related]
7. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of combined use of ursodeoxycholic acid and heptral in the treatment of primary biliary cirrhosis].
Avezov SA; Mansurova FKh
Klin Med (Mosk); 2004; 82(2):46-9. PubMed ID: 15106512
[TBL] [Abstract][Full Text] [Related]
9. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial.
Villa E; Grottola A; Buttafoco P; Colantoni A; Bagni A; Ferretti I; Cremonini C; Bertani H; Manenti F
Am J Gastroenterol; 2001 Oct; 96(10):2973-7. PubMed ID: 11693335
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
[TBL] [Abstract][Full Text] [Related]
11. Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial.
Israeli E; Safadi R; Melhem A; Pappo O; Shibolet O; Klein A; Hemed N; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Liver Int; 2004 Aug; 24(4):295-307. PubMed ID: 15287852
[TBL] [Abstract][Full Text] [Related]
12. Alterations of leptin during IFN-alpha therapy in patients with chronic viral hepatitis.
Zografos TA; Rigopoulou EI; Liaskos C; Togousidis E; Zachou K; Gatselis N; Germenis A; Dalekos GN
J Hepatol; 2006 May; 44(5):848-55. PubMed ID: 16530290
[TBL] [Abstract][Full Text] [Related]
13. Gut-liver axis: a new point of attack to treat chronic liver damage?
Loguercio C; De Simone T; Federico A; Terracciano F; Tuccillo C; Di Chicco M; Cartenì M
Am J Gastroenterol; 2002 Aug; 97(8):2144-6. PubMed ID: 12190198
[No Abstract] [Full Text] [Related]
14. [Computerized histological analysis in chronic viral hepatitis].
Hassan C; Tavani PD; Serafini B
Pathologica; 1999 Jun; 91(3):173-8. PubMed ID: 10536462
[TBL] [Abstract][Full Text] [Related]
15. Successful application of highly purified natural interferon alpha (multiferon) in a chronic hepatitis C patient resistant to preceding treatment approaches.
Musch E; Malek M; von Eick H; Chrissafidou A
Hepatogastroenterology; 2004; 51(59):1476-9. PubMed ID: 15362781
[TBL] [Abstract][Full Text] [Related]
16. Serum thrombopoietin levels in thrombocytopenic patients with liver cirrhosis.
Vyzantiadis T; Theodoridou S; Giouleme O; Evgenidis N; Vyzantiadis A; Garipidou V
Haematologica; 2002 Aug; 87(8):890-1. PubMed ID: 12161370
[No Abstract] [Full Text] [Related]
17. Treatment with alpha-interferon in chronic hepatitis.
Matei I; Tănăsescu C; Voiosu R; Murariu E; Dragomir P; Serbănescu A
Rom J Intern Med; 1998; 36(3-4):227-37. PubMed ID: 10822519
[TBL] [Abstract][Full Text] [Related]
18. Heptral (ademetionine) in patients with intrahepatic cholestasis in chronic liver disease due to non-alcoholic liver disease: results of a multicentre observational study in India.
Virukalpattigopalratnam MP; Singh T; Ravishankar AC
J Indian Med Assoc; 2013 Dec; 111(12):856-9. PubMed ID: 25154164
[TBL] [Abstract][Full Text] [Related]
19. Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4.
Panasiuk A; Prokopowicz D; Zak J; Matowicka-Karna J; Osada J; Wysocka J
Hepatogastroenterology; 2001; 48(39):818-22. PubMed ID: 11462931
[TBL] [Abstract][Full Text] [Related]
20. Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial.
Mazzella G; Saracco G; Festi D; Rosina F; Marchetto S; Jaboli F; Sostegni R; Pezzoli A; Azzaroli F; Cancellieri C; Montagnani M; Roda E; Rizzetto M
Am J Gastroenterol; 1999 Aug; 94(8):2246-50. PubMed ID: 10445557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
